Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Knowing when to change your investment strategy is crucial. Discover key signs that indicate it's time to adapt.
24,241 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
You’ve got $1,500 to invest for a three-year horizon. This guide compares XRP and Cardano, weighing risk, potential u...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
When the market shakes, a top-tier stock can become a compelling bargain. This guide breaks down why one Magnificent ...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
A high-profile Nvidia deal has propelled a semiconductor stock into the spotlight. This article breaks down whether t...
Nvidia investors are watching a major update that could define the stock’s next phase. This guide breaks down what to...
The Trade Desk faced another slide as investors weighed AI-driven competition and fee pressure. This deep dive breaks...
Broadcom heads into a pivotal Q2 earnings report, with AI demand and data-center growth fueling momentum. This guide ...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
Memory demand tied to AI and data centers has Micron at a pivotal moment. This guide breaks down whether micron stock...